We present 24-hour electrocardiography recording with observed DDD pacemaker pacing inhibition. Discussed Holter monitoring fi ndings are puzzling and may result from pacemaker sensing malfunction. However, its aetiology may be diverse. The detailed explanation of underlying mechanisms is provided and literature is reviewed.
Introduction
Analysis of electrocardiography (ECG) recording in patients with cardiovascular implantable electronic devices (CIED) may be challenging. We would like to approach this issue in a problem-based learning manner.
An 80-year-old woman with a history of arterial hypertension, dyslipidaemia, hypothyreosis, and a dual-chamber pacemaker (DDD, St. Jude Medical Verity ADx XLDR) presented to clinic for routine follow-up. She reported worse disposition, weakness and dizziness for 2 months. Her pacemaker was interrogated. The pacemaker was programmed to DDD pacing mode. Table 1 shows the basic pacing programming of the device.
DDD pacemaker was implanted due to signifi cant bradycardia and sick sinus syndrome. Active fi xation, bipolar, ventricular lead (Medtronic, CapSureFixNovus) was implanted into right ventricular outfl ow tract (RVOT) through left subclavian vein puncture, while another passive fi xation, bipolar (Biotronik, Synox SX 53 JBP) atrial lead was located within right atrial appendage using left cephalic vein venesection. The Holter ECG monitoring was performed and its selected parts are shown on Figure 1 . What caused the 
Discussion
In pacemaker-dependent patients, pacemaker inhibition may result in syncope, imbalance and/or dizziness recurrence. This fi nding may be recorded during Holter ECG monitoring [1] . Very similar ECG recordings can be seen with different mechanisms. Most physicians know that it may be the result of myopotentials noise in the presence of unipolar leads or when unipolar sensing is turned on [2] . Presented patient history suggests pacemaker malfunction, but no unipolar lead was implanted. In the presence of bipolar leads, inhibition of pacemaker programmed into bipolar sensing should not occur [3] . However, pacing inhibition during bipolar sensing may take place when the lead is damaged [4] or when some algorithms promoting endogenous ventricular depolarization are turned on [5, 6] .
Exact interpretation of recorded fi ndings in our patient is possible in the context of basic DDD pacemaker time intervals understanding, which include: -lower rate interval (LRI) -the longest interval, during which no sensed events are observed; it is measured from paced or sensed ventricular event to the following paced ventricular stimulus; -paced atrioventricular interval (PAVI) -timeframe between atrial pacing and programmed ventricular pacing; -atrial escape interval (AEI), also called V-A intervaltimeframe measured from sensed or paced ventricular event to atrial stimulus, provided that no atrial or ventricular event is sensed (AEI = LRI -PAVI);
-ventricular refractory period (VRP) -interval that begins with ventricular event during which ventricular lead sensing is blocked, therefore no LRI may begin. Movements of the pacemaker pocket region during pacemaker control may help to put the right diagnosis. Figure 2 shows resting ECG and EGM which reveal DDD pacemaker inhibition during this practical manoeuvre. Due to damaged ventricular lead, pacemaker lead movements caused noise oversensing, which was interpreted by the pacemaker as ventricular activity (VS, visible in marker channel) and led to pacemaker inhibition (both atrial and ventricular pacing was inhibited). Atrial lead was in working order and did not read noise from ventricular lead (marker channel), from the heart or damaged atrial lead (which would lead to only atrial pacing inhibition).
Pacemaker inhibition may be caused by old and efficient unipolar leads (or new ones programmed to unipolar sensing) which may read myopotentials from the thoracic or even abdominal muscles [7] . Against pacemaker inhibition by myopotentials or electromagnetic fi eld, in this case, is the fact, that artefacts were present only in the ventricular channel. This would not be possible, when both unipolar leads would be implanted. On the other hand, in the case of algorithms promoting endogenous ventricular depolarization (i.e. Medtronic's Minimal Ventricular Pacing algorithm) no noise would be observed.
In our case, pacing system included new (ca. 10-year--old) bipolar leads which advantage should be resistance towards reading noise from skeletal muscles myopotentials and from external electromagnetic fields. The cause of pacemaker inhibition was ventricular lead damage. Which could be also suggestive, it is more common when 
